NCT06523764View on ClinicalTrials.gov

Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

October 1, 2025

Conditions
Helicobacter Pylori Infection Chronic Gastrit
Interventions
DRUG

tegoprazan

tegoprazan 50 mg and minocycline 100 mg by mouth, twice daily for 14 days

DRUG

Minocycline

tegoprazan 50 mg and minocycline 100 mg by mouth, twice daily for 14 days

DRUG

bismuth potassium citrate

bismuth potassium citrate 240 mg,esomeprazole 40 mg, amoxicillin 1000mg, and clarithromycin 500 mg by mouth,twice daily for 14 days

DRUG

Esomeprazole 40mg

bismuth potassium citrate 240 mg,esomeprazole 40 mg, amoxicillin 1000mg, and clarithromycin 500 mg by mouth,twice daily for 14 days

DRUG

Amoxicillin

bismuth potassium citrate 240 mg,esomeprazole 40 mg, amoxicillin 1000mg, and clarithromycin 500 mg by mouth,twice daily for 14 days

DRUG

clarithromycin

bismuth potassium citrate 240 mg,esomeprazole 40 mg, amoxicillin 1000mg, and clarithromycin 500 mg by mouth,twice daily for 14 days

Trial Locations (1)

710032

Xijing hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital of Digestive Diseases

OTHER